TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio-Works Technologies AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
2,217
|
3,956
|
3,713 |
| Financial expenses |
1
|
0
|
2 |
| Earnings before taxes |
-3,246
|
-4,933
|
-4,016 |
| EBITDA |
-3,263
|
-5,023
|
-4,100 |
| Total assets |
4,570
|
5,601
|
8,232 |
| Current assets |
4,412
|
5,377
|
8,014 |
| Current liabilities |
689
|
1,633
|
2,150 |
| Equity capital |
3,881
|
3,968
|
6,083 |
| - share capital |
679
|
351
|
316 |
| Employees (average) |
33
|
39
|
43 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
84.9%
|
70.8%
|
73.9% |
| Turnover per employee |
67
|
101
|
86 |
| Profit as a percentage of turnover |
-146.4%
|
-124.7%
|
-108.2% |
| Return on assets (ROA) |
-71.0%
|
-88.1%
|
-48.8% |
| Current ratio |
640.3%
|
329.3%
|
372.7% |
| Return on equity (ROE) |
-83.6%
|
-124.3%
|
-66.0% |
| Change turnover |
-1,605
|
232
|
1,744 |
| Change turnover % |
-42%
|
6%
|
89% |
| Chg. No. of employees |
-6
|
-4
|
11 |
| Chg. No. of employees % |
-15%
|
-9%
|
34% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.